Fourier Transform Spectrometer for Drug Detection Research

The National Institute of Standards and Technology (NIST), Sensor Science Division, is developing new infrared drug sensors based on metamaterials. To support this effort and fulfill the requirements of the Testing, Rapid Analysis, and Narcotic Quality (TRANQ) Research Act of 2023, NIST requires a compact Fourier-transform spectrometer (FTS). This FTS will be used for spectroscopic detection of drug molecules in the 2 mm to 11 mm wavelength range, enabling the measurement of sensor response and the development of deployable drug detection platforms. The FTS must meet specific minimum requirements, including a spectral range of 2 to 11 mm (or greater), a spectral resolution of 0.5 cm-1 or better, a compact design (18 cm x 16 cm x 8 cm without detector), and compatibility with a user-supplied light source and an MCT-cooled detector. NIST is seeking information from potential sources capable of providing such equipment. If no alternative sources are identified, NIST intends to issue a sole source award to Bruker Scientific, LLC.